Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
MIPH.CA Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: December 27, 2025
Report Source: 2025 3rd Quarter Report
Minapharm Pharmaceuticals SAE. Stock Analysis MIPH.CA
Egypt Health Care Micro Cap Report: Minapharm Pharmaceuticals engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Cairo, Cairo. The company went IPO on 2004-01-11. The Company’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex, broncho-vaxom adult, broncho-vaxom infantile, burinex, chlorhexidine tulle, chlorhexidine tulle, ciloprine, daktacort cream, daktarin cream, desatura, dicynone, among others. Minapharm is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.
Read More Minapharm Pharmaceuticals SAE (MIPH.CA) Chart
Key Statistics of Minapharm Pharmaceuticals SAE (MIPH.CA)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
EGP696.00Volume
4534.00P/E Ratio (TTM)
50.2252 Week Range
Market Cap
7.31BAvg. Volume
2910.56Dividend Yield
0.66%Financial Metrics & Statements of Minapharm Pharmaceuticals SAE (MIPH.CA)
FAQ's for Minapharm Pharmaceuticals SAE (MIPH.CA)
- According to Musaffa’s Shariah screening methodology, Minapharm Pharmaceuticals SAE (MIPH.CA) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Minapharm Pharmaceuticals SAE using these criteria to determine its compliance status.
- Muslim investors may consider investing in Minapharm Pharmaceuticals SAE if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Minapharm Pharmaceuticals SAE by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Minapharm Pharmaceuticals SAE may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Minapharm Pharmaceuticals SAE on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.